Fractionated administration of irinotecan and cisplatin for treatment of non-small-cell lung cancer: a phase II study of Okayama Lung Cancer Study Group

A phase II study of fractionated administration of irinotecan (CPT-11) and cisplatin (CDDP) in patients with non-small-cell lung cancer (NSCLC) was conducted. Between January 1996 and January 1998, 44 previously untreated patients with stage IIIB or IV NSCLC were enrolled. CDDP at a dose of 60 mg m(...

Descripción completa

Detalles Bibliográficos
Autores principales: Ueoka, H, Tanimoto, M, Kiura, K, Tabata, M, Takigawa, N, Segawa, Y, Takata, I, Eguchi, K, Okimoto, N, Harita, S, Kamei, H, Shibayama, T, Watanabe, Y, Hiraki, S, Harada, M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2001
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363923/
https://www.ncbi.nlm.nih.gov/pubmed/11437395
http://dx.doi.org/10.1054/bjoc.2001.1861

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363923/
https://www.ncbi.nlm.nih.gov/pubmed/11437395
http://dx.doi.org/10.1054/bjoc.2001.1861

Ejemplares similares